Drugs / FMT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03720392 | Jan 2019 → May 2020 | disease related to hematopoietic stem cell transplant | Zachariah Michael DeFilipp | Terminated | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03720392 ↗ |
| Action | Restore | “FMT administration may play a role in restoring higher microbial flora diversity in the gut.” NCT03720392 ↗ |
| Modality | Other / unclassified | “FMT is a process utilizing microbial components” NCT03720392 ↗ |
| Route | Oral | “A standard dose of oral FMT is 15 capsules per day for two consecutive days,” NCT03720392 ↗ |